DSM Pharmaceuticals completed an expansion to its sterile parenteral manufacturing facility in Greenville, NC, adding a Clinical Trial Material manufacturing suite capable of manufacturing large and small molecule liquid and lyophilized products for Phase I-III trials.

“What’s resulted is an expanded service offering consistent with the level of high quality service and deliverables our customers have come to expect from DSM,” said Terry Novak, chief marketing officer, DSM Pharmaceuticals. “For customers with sterile products in development, they can now start with DSM in clinical trial manufacturing and stay with DSM through commercial manufacturing.”

With this new manufacturing facility, DSM now offers comprehensive services with optional support services such as, QA audits, regulatory support, lyophilization cycle development; analytical methods development and testing.